The Division for Drug Discovery and Development (DDD) assists pharmacologists in industry, government and academia
with interests in all phases of the drug development process. The goal
of the Division is to promote interaction between discovery scientists,
physicians and regulators as we attempt to integrate the broad expanse
of skills required to translate the identification of a novel molecular
target into a clinically useful therapeutic entity.
Bradford Fischer, Remy Brim, and Azusa Takahashi won awards in this year's competition...
Minutes are now available from the Annual Executive Committee Meeting held on April 25, 2010 in Anaheim, California. View/Download PDF
DDDRA generously provided $5,000.00 in support of the IUPHAR General Assembly at the upcoming WorldPharma2010 meeting in Copenhagen this summer.
The DDD will serve to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics. DDD sponsors symposia and/or colloquia on timely, related topics at annual meetings. Furthermore, the Division provides special venues at theses meetings for graduate students and post-doctoral fellows with related research activities and interests to present and discuss their work in a relaxed, social setting with other students, fellows and DDD members.
© Copyright 2012
The American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, Maryland 20814-3995
ASPET.org is best viewed with Internet Explorer 7+, Firefox 3.5+ and Safari 3+.